Related Experiment Videos
Pharmacologic evaluation of standard and controlled-release disopyramide
Angiology
|February 1, 1987
Summary
Controlled-release disopyramide offers improved patient compliance and potentially fewer side effects compared to standard formulations. This new antiarrhythmic drug formulation shows promise for increasing the clinical usefulness of disopyramide.
Area of Science:
- Pharmacology
- Drug Delivery Systems
Background:
- Standard disopyramide formulations present challenges in patient compliance and managing concentration-related adverse effects.
- Controlled-release drug formulations offer potential benefits including improved adherence and predictable pharmacologic effects.
Purpose of the Study:
- To describe the pharmacology of disopyramide.
- To evaluate the advantages and disadvantages of controlled-release formulations.
- To present preliminary findings on the use of controlled-release disopyramide.
Main Methods:
- Pharmacological review of disopyramide.
- Analysis of sustained-release formulation principles.
- Preliminary clinical observation of controlled-release disopyramide.
Main Results:
- Controlled-release disopyramide demonstrated potential for enhanced patient compliance.
- The formulation may reduce concentration-related adverse effects associated with disopyramide.
- Preliminary findings suggest predictable pharmacologic effects.
Conclusions:
- Controlled-release disopyramide is a promising new antiarrhythmic formulation.
- This formulation may significantly increase the clinical utility of disopyramide in managing arrhythmias.